title: Refractory Kawasaki disease: infliximab or methotrexate therapy?
authors.forename: Jae Il
authors.initials: JI
authors.lastname: Shin
authors.forename: Jae Seung
authors.initials: JS
authors.lastname: Lee
authors.forename: Jae Young
authors.initials: JY
authors.lastname: Choi
authors.forename: Dong Soo
authors.initials: DS
authors.lastname: Kim
authors.forename: Meenakshi
authors.initials: M
authors.lastname: Girish
authors.lastname: Subramaniam
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002675:Child, Preschool; D006801:Humans; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use*; D009080:Mucocutaneous Lymph Node Syndrome / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000627:therapeutic use*
chemical_list: D000893:Anti-Inflammatory Agents; D014409:Tumor Necrosis Factor-alpha; D008775:Methylprednisolone